These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24980839)

  • 1. Drug eluting stents and the critical path initiative: Evolving paradigms for safety evaluation.
    Sanhai WR; Stockbridge N; Fiorentino RP; Uchida T; Uhl K; Krucoff MW
    Drug Discov Today Technol; 2007; 4(2):43-6. PubMed ID: 24980839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical path approach to advance nanoengineered medical products.
    Sanhai WR; Spiegel J; Ferrari M
    Drug Discov Today Technol; 2007; 4(2):35-41. PubMed ID: 24980838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.
    Bangalore S; Amoroso N; Fusaro M; Kumar S; Feit F
    Circ Cardiovasc Interv; 2013 Aug; 6(4):378-90. PubMed ID: 23922145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory issues facing the development of drug-eluting stents: a US FDA perspective.
    Boam AB
    Expert Rev Med Devices; 2006 May; 3(3):297-300. PubMed ID: 16681451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
    Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
    Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New DES: a new step forward?
    Ko BS; Meredith IT
    Minerva Cardioangiol; 2012 Feb; 60(1):41-56. PubMed ID: 22322573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Valgimigli M; Frati G; Kedhi E; Smits PC; Kaiser C; Genereux P; Galatius S; Kirtane AJ; Stone GW
    J Am Coll Cardiol; 2013 Aug; 62(6):496-504. PubMed ID: 23747778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late stent thrombosis: the Damocle's sword of drug eluting stents?
    Rodriguez AE; Rodriguez-Granillo GA; Palacios IF
    EuroIntervention; 2007 Feb; 2(4):512-7. PubMed ID: 19755294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stent thrombosis in the era of drug-eluting stents].
    Wöhrle J
    Herz; 2007 Aug; 32(5):411-8. PubMed ID: 17687531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the landscape of stent thrombosis: the drug-eluting versus bare-metal stent controversy.
    Rizik DG; Klassen KJ
    Am J Cardiol; 2008 Nov; 102(9 Suppl):4J-11J. PubMed ID: 18928786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of drug eluting stents versus bare metal stents in ST-elevation myocardial infarction: a contemporary review.
    Bokhoor PI; Lee MS
    Minerva Cardioangiol; 2011 Feb; 59(1):49-59. PubMed ID: 21285931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
    De Luca G; Dirksen MT; Spaulding C; Kelbaek H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Díaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Cortese G; Suryapranata H; Stone GW;
    Arch Intern Med; 2012 Apr; 172(8):611-21; discussion 621-2. PubMed ID: 22529227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label use of stents: bare-metal versus drug-eluting stents.
    Girod JP; Mulukutla SR; Marroquin OC
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1095-106. PubMed ID: 18793112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased rate of stent thrombosis with DES].
    Kaiser C; Pfisterer M
    Herz; 2007 Jun; 32(4):296-300. PubMed ID: 17607536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.